Hamdy Ahmed MD 4
4 · Vincerx Pharma, Inc. · Filed Aug 10, 2023
Insider Transaction Report
Form 4
Hamdy Ahmed MD
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Common Stock
2023-08-10$0.96/sh+5,400$5,167→ 96,060 total(indirect: By Trust) - Purchase
Common Stock
2023-08-09$0.95/sh+16,900$15,994→ 90,660 total(indirect: By Trust)
Holdings
- 1,618,199
Common Stock
Footnotes (2)
- [F1]Represents a weighted average purchase price. Actual purchase prices ranged from $0.88 to $0.95 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.
- [F2]Represents actual price.